Shambhavi Naik

Tag

Takshashila Discussion SlideDoc – A COVID-19 Vaccine Deployment Strategy for India

Download the Discussion SlideDoc in PDF by Shambhavi Naik, Ameya Paleja, Mihir Mahajan, Narayan Ramachandran, Sunila Dixit, Rahul Matthan, Nitin Pai and Pranay Kotasthane India should aim to vaccinate 80% of the population by 31st December 2021. There are 4...

Takshashila Discussion Slidedoc: Gene Drives in Infectious Diseases – A Risk Assessment

By Shambhavi Naik Download the Slidedoc in PDF [1.5 MB] Gene drives are being explored for alleviating vector-borne infectious diseases however, the risks of employing them need to be understood. This Slidedoc assesses the potential use of gene drives in...

Takshashila Policy Advisory – COVID-19: Healthcare Measures to Tackle a Second Wave in India

Executive Summary Countries worldwide are bracing for a second wave of COVID-19 infections in the coming months. A second wave is a resurgence in infections after the existing cases appear to be reducing. This document proposes a series of measures...

Takshashila Discussion SlideDoc: Increasing COVID-19 Testing Capacity in India

By Shambhavi Naik Executive Summary: The response to the COVID-19 pandemic rests on the ability to test for infected patients quickly and at scale. Exhaustive testing underpins effective containment strategies, helps estimate healthcare requirements and decreases the toll on delivery...

Takshashila Blue Paper: A Framework for Governing Human Gene Editing in India

Download the Blue Paper in PDF [430 KB] This Blue Paper was prepared as a result of a roundtable discussion organised by the Takshashila Institution on 15 December 2017, based on the Discussion Document: A Framework for Governing Gene Editing....

Takshashila Policy Advisory – Comments on the National Guidelines for Gene Therapy Product Development and Clinical Trials

Download the Advisory in PDF This policy advisory contains recommendations and comments in response to the draft National Guidelines for Gene Therapy Product Development and Clinical Trials released by the Indian Council of Medical Research (ICMR) in consultation with the...

Takshashila Conducts Roundtable Discussion on Governing Gene Editing

The Takshashila Institution conducted a Roundtable on the Governance of Gene Editing at their office on 15 December 2017. The advent of new gene editing methods like CRISPR-Cas9 have increased the potential of gene editing technologies with their increased precision and reduced costs. This has brought decade old...

Discussion Document: A Framework for Governing Gene Editing

By Madhav Chandavarkar, Anirudh Kanisetti, Shambhavi Naik, and Ajay Patri Download the Discussion Document in PDF [1.2 MB] Executive Summary Gene editing offers many benefits. They range from basic research that can enhance the scientific understanding of gene functions to...